Oppenheimer articles
-
How Historical Revisionism Hides ‘Oppenheimer’s’ Secrets
Since its release in the summer of 2023, critics and fans have not stopped talking about Christopher Nolan’s Oppenheimer. But the more I watch and read people’s views on the film, the more I suspect that a large number of us completely missed the artistic thrust of the project. Oppenheimer, based on the Pulitzer-winning book
-
Generac (NYSE:GNRC) PT Raised to $145.00 at Oppenheimer
Generac (NYSE:GNRC – Get Free Report) had its target price hoisted by equities researchers at Oppenheimer from $140.00 to $145.00 in a report issued on Thursday, Benzinga reports. The brokerage currently has an “outperform” rating on the technology company’s stock. Oppenheimer’s target price would indicate a potential upside of 8.71% from the company’s previous close. […]
-
Neurocrine Biosciences (NASDAQ:NBIX) PT Raised to $216.00 at Oppenheimer
Neurocrine Biosciences (NASDAQ:NBIX – Get Free Report) had its price objective lifted by research analysts at Oppenheimer from $200.00 to $216.00 in a research report issued on Thursday, Benzinga reports. The brokerage presently has an “outperform” rating on the stock. Oppenheimer’s target price would suggest a potential upside of 53.51% from the stock’s previous close. […]